Long-acting (LA) antiretrovirals may provide meaningful benefit to people who use drugs and people experiencing homelessness (PEH) who face disproportionate structural and psychosocial barriers in adhering to daily oral HIV antiretroviral therapy or pre-exposure prophylaxis (PrEP), but their use in these populations has not been studied.
No takes yet. Share an insight, caveat, or question.
Mehtani et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: